
|Videos|March 30, 2022
AMCP 2022: Michael Ciarametaro of National Pharmaceutical Council Talks Gene Therapy, Medicaid Best Price Rule
Author(s)MHE Staff
Michael Ciarametaro, MBA, National Pharmaceutical Council National discusses gene therapy and the Medicaid Best Price Rule with MHE during the annual AMCP conference in Chicago.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Researchers discover new pathway to fight liver inflammation
2
FDA approves $2.7 million gene therapy for rare metabolic disorder
3
Overlooked bladder nerves now thought to reduce UTI burden through pain signaling, study shows
4
HIV medication adherence follows SNAP payment timing, study finds
5






















